Minerva Surgical Inc. (UTRS)
OTC: UTRS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Mar 06, 2025, 3:00 PM
Minerva Surgical Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.96M | 13.39M | 12.53M | 13.8M | 12.59M | 12.97M | 10.94M | 13.64M | 12.51M | 14.11M | 11.84M |
Cost of Revenue | 5.75M | 5.99M | 5.52M | 6.43M | 5.78M | 5.32M | 5.52M | 5.82M | 5.37M | 5.38M | 5M |
Gross Profit | 6.22M | 7.4M | 7.01M | 7.37M | 6.81M | 7.64M | 5.41M | 7.83M | 7.13M | 8.73M | 6.83M |
Operating Income | -6.1M | -7.66M | -10.31M | -5.19M | -10.51M | -4.9M | -10.3M | -6.65M | -6.14M | -11.56M | -4.79M |
Interest Income | 92K | 147K | 38K | 19K | 42K | 19K | 9K | 10K | n/a | n/a | 1K |
Pretax Income | -7.18M | -8.64M | -11.34M | -6.23M | -11.33M | -5.61M | -10.93M | 10.82M | -3.23M | -14.1M | -14.95M |
Net Income | -7.18M | -8.68M | -13.44M | -6.25M | -11.33M | -6.33M | -11.55M | 10.81M | -3.23M | -14.1M | -14.95M |
Selling & General & Admin | 10.9M | 13.58M | 15.56M | 11.11M | 15.87M | 11.27M | 14.46M | 13.38M | 11.91M | 18.62M | 10.47M |
Research & Development | 1.41M | 1.48M | 1.76M | 1.46M | 1.46M | 1.27M | 1.25M | 1.1M | 1.37M | 1.67M | 1.15M |
Other Expenses | n/a | -2K | -3K | -35K | -2K | -30K | -2K | 204K | -4K | 48K | -587K |
Operating Expenses | 12.31M | 15.06M | 17.32M | 12.56M | 17.32M | 12.54M | 15.71M | 14.48M | 13.27M | 20.3M | 11.62M |
Interest Expense | 1.17M | 1.13M | 1.07M | 1.03M | 861K | 703K | 632K | 1.06M | 3.61M | 3.6M | 3.45M |
Selling & Marketing Expenses | 6.71M | 9.36M | 10.2M | 9.44M | 9.72M | 9.69M | 9.47M | 9.31M | 7.92M | 8.5M | 6.47M |
Cost & Expenses | 18.06M | 21.05M | 22.84M | 19M | 23.1M | 17.87M | 21.23M | 20.3M | 18.65M | 25.68M | 16.63M |
Income Tax Expense | 3K | 39K | 2.1M | 11K | 859K | 714K | 625K | 9K | 993K | 3.65M | 2.86M |
Shares Outstanding (Basic) | 8.87M | 8.85M | 4.78M | 29.57M | 1.43M | 1.43M | 1.42M | 1.44M | 1.43M | 1.02M | 1.02M |
Shares Outstanding (Diluted) | 8.87M | 8.85M | 4.78M | 29.57M | 1.43M | 1.43M | 1.42M | 1.44M | 1.43M | 1.02M | 1.02M |
EPS (Basic) | -0.81 | -0.98 | -2.81 | -0.21 | -7.92 | -4.43 | -8.11 | 7.50 | -2.26 | -13.82 | -14.66 |
EPS (Diluted) | -0.81 | -0.98 | -2.81 | -0.21 | -7.92 | -4.43 | -8.11 | 7.50 | -2.26 | -13.82 | -14.66 |
EBITDA | -4.56M | -5.53M | -10.28M | -5.21M | -7.78M | -2.22M | -7.63M | -6.44M | -6.14M | -8.82M | -2.73M |
EBIT | -6.01M | -7.51M | -10.28M | -5.21M | -10.47M | -4.91M | -10.29M | 11.88M | 386K | -10.5M | -11.5M |
Depreciation & Amortization | 1.45M | 1.98M | 35K | -16K | 2.69M | 2.68M | 2.67M | 2.67M | 2.61M | 2.69M | 2.64M |